{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T16:40:22Z","timestamp":1740156022480,"version":"3.37.3"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2021,8,10]],"date-time":"2021-08-10T00:00:00Z","timestamp":1628553600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2021,8,10]],"date-time":"2021-08-10T00:00:00Z","timestamp":1628553600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Can J Anesth\/J Can Anesth"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1007\/s12630-021-02081-4","type":"journal-article","created":{"date-parts":[[2021,8,10]],"date-time":"2021-08-10T17:03:00Z","timestamp":1628614980000},"page":"1641-1650","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Epidemiology of intravenous immune globulin in septic shock: a retrospective cohort analysis of the Premier Healthcare Database","\u00c9pid\u00e9miologie de l\u2019utilisation de l\u2019immunoglobuline intraveineuse dans les cas de choc septique\u00a0: une analyse de cohorte r\u00e9trospective de la base de donn\u00e9es Premier Healthcare"],"prefix":"10.1007","volume":"68","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7645-0791","authenticated-orcid":false,"given":"Murdoch","family":"Leeies","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hayley B.","family":"Gershengorn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emmanuel","family":"Charbonney","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anand","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dean A.","family":"Fergusson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexis F.","family":"Turgeon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Allan","family":"Garland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Donald S.","family":"Houston","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brett","family":"Houston","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emily","family":"Rimmer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric","family":"Jacobsohn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Srinivas","family":"Murthy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rob","family":"Fowler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Balshaw","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryan","family":"Zarychanski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,8,10]]},"reference":[{"key":"2081_CR1","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1097\/00003246-200107000-00002","volume":"29","author":"DC Angus","year":"2001","unstructured":"Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, Pinsky MR. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med 2001; 29: 1303-10.","journal-title":"Crit Care Med"},{"key":"2081_CR2","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1001\/jama.1995.03530120060042","volume":"274","author":"C Brun-Buisson","year":"1995","unstructured":"Brun-Buisson C, Doyon F, Carlet J, et al. Incidence, risk factors, and outcome of severe sepsis and septic shock in adults. A multicenter prospective study in intensive care units. French ICU Group for Severe Sepsis. JAMA 1995; 274: 968-74.","journal-title":"JAMA"},{"key":"2081_CR3","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.1056\/NEJMoa022139","volume":"348","author":"GS Martin","year":"2003","unstructured":"Martin GS, Mannino DM, Eaton S, Moss M. The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med 2003; 348: 1546-54.","journal-title":"N Engl J Med"},{"key":"2081_CR4","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2016.0287","author":"M Singer","year":"2016","unstructured":"Singer M, Deutschman CS, Seymour CW, et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA 2016. DOI: https:\/\/doi.org\/10.1001\/jama.2016.0287.","journal-title":"JAMA"},{"key":"2081_CR5","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.ccm.2016.01.015","volume":"37","author":"EJ Seeley","year":"2016","unstructured":"Seeley EJ, Bernard GR. Therapeutic targets in sepsis: past, present, and future. Clin Chest Med 2016; 37: 181-9.","journal-title":"Clin Chest Med"},{"key":"2081_CR6","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1001\/jama.2016.0289","volume":"315","author":"M Shankar-Hari","year":"2016","unstructured":"Shankar-Hari M, Phillips GS, Levy ML, et al. Developing a new definition and assessing new clinical criteria for septic shock: for the Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA 2016; 315: 775-87.","journal-title":"JAMA"},{"key":"2081_CR7","unstructured":"World Health Organization. ANTIMICROBIAL RESISTANCE Global Report on Surveillance 2014. Available from URL: https:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/112642\/9789241564748_eng.pdf;jsessionid=E1DA117735B9320708C784ED6D35E911?sequence=1 (accessed June 2021)."},{"key":"2081_CR8","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-014-0649-z","author":"MO Soares","year":"2014","unstructured":"Soares MO, Welton NJ, Harrison DA, et al. Intravenous immunoglobulin for severe sepsis and septic shock: clinical effectiveness, cost-effectiveness and value of a further randomised controlled trial. Crit Care 2014. DOI: https:\/\/doi.org\/10.1186\/s13054-014-0649-z.","journal-title":"Crit Care"},{"key":"2081_CR9","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1007\/s00134-012-2769-8","volume":"39","author":"RP Dellinger","year":"2013","unstructured":"Dellinger RP, Levy MM, Rhodes A, et al. Surviving Sepsis Campaign: International guidelines for management of severe sepsis and septic shock, 2012. Intensive Care Med 2013; 39: 165-228.","journal-title":"Intensive Care Med"},{"key":"2081_CR10","doi-asserted-by":"publisher","DOI":"10.1513\/AnnalsATS.201604-259OC","author":"EA Vail","year":"2016","unstructured":"Vail EA, Gershengorn HB, Hua M, Walkey AJ, Wunsch H. Epidemiology of vasopressin use for adults with septic shock. Ann Am Thorac Soc 2016. DOI: https:\/\/doi.org\/10.1513\/AnnalsATS.201604-259OC.","journal-title":"Ann Am Thorac Soc"},{"key":"2081_CR11","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.1097\/CCM.0000000000000305","volume":"42","author":"K Raghunathan","year":"2014","unstructured":"Raghunathan K, Shaw A, Nathanson B, et al. Association between the choice of IV crystalloid and in-hospital mortality among critically ill adults with sepsis. Crit Care Med 2014; 42: 1585-91.","journal-title":"Crit Care Med"},{"key":"2081_CR12","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1097\/CCM.0b013e31829eb7c9","volume":"42","author":"JS Steingrub","year":"2014","unstructured":"Steingrub JS, Lagu T, Rothberg MB, Nathanson BH, Raghunathan K, Lindenauer PK. Treatment with neuromuscular blocking agents and the risk of in-hospital mortality among mechanically ventilated patients with severe sepsis. Crit Care Med 2014; 42: 90-6.","journal-title":"Crit Care Med"},{"key":"2081_CR13","unstructured":"Premier Incorporated. Premier Healthcare Database White Paper: Data that informs and performs. Prem Appl Sci 2018. Available from URL: https:\/\/www.premierinc.com\/newsroom\/education\/premier-healthcare-database-whitepaper (accessed June 2021)."},{"key":"2081_CR14","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1097\/01.CCM.0000217961.75225.E9","volume":"34","author":"A Kumar","year":"2006","unstructured":"Kumar A, Roberts D, Wood KE, et al. Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med 2006; 34: 1589-96.","journal-title":"Crit Care Med"},{"key":"2081_CR15","first-page":"960","volume":"330","author":"M Mamdani","year":"2005","unstructured":"Mamdani M, Sykora K, Li P, et al. Reader\u2019s guide to critical appraisal of cohort studies: 2. Assessing potential for confounding. BMJ 2005; 330: 960-2.","journal-title":"Assessing potential for confounding. BMJ"},{"key":"2081_CR16","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001090.pub2","author":"MM Alejandria","year":"2013","unstructured":"Alejandria MM, Lansang MA, Dans LF, Blas Mantaring III J. Intravenous immunoglobulin for treating sepsis, severe sepsis and septic shock. Cochrane Database Syst Rev 2013. DOI: https:\/\/doi.org\/10.1002\/14651858.CD001090.pub2.","journal-title":"Cochrane Database Syst Rev"},{"key":"2081_CR17","first-page":"2677","volume":"35","author":"KG Kreymann","year":"2007","unstructured":"Kreymann KG, de Heer G, Nierhaus A, Kluge S. Use of polyclonal immunoglobulins as adjunctive therapy for sepsis or septic shock. Crit Care Med 2007; 35: 2677-85.","journal-title":"Crit Care Med"},{"key":"2081_CR18","first-page":"2686","volume":"35","author":"KB Laupland","year":"2007","unstructured":"Laupland KB, Kirkpatrick AW, Delaney A. Polyclonal intravenous immunoglobulin for the treatment of severe sepsis and septic shock in critically ill adults: a systematic review and meta-analysis. Crit Care Med 2007; 35: 2686-92.","journal-title":"Crit Care Med"},{"key":"2081_CR19","doi-asserted-by":"publisher","first-page":"193","DOI":"10.7326\/0003-4819-146-3-200702060-00009","volume":"146","author":"AF Turgeon","year":"2007","unstructured":"Turgeon AF, Hutton B, Fergusson DA, et al. Meta-analysis: intravenous immunoglobulin in critically ill adult patients with sepsis. Ann Intern Med 2007; 146: 193-203.","journal-title":"Ann Intern Med"},{"key":"2081_CR20","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1111\/j.1365-2796.2006.01726.x","volume":"260","author":"A Norrby-Teglund","year":"2006","unstructured":"Norrby-Teglund A, Haque KN, Hammarstrom L. Intravenous polyclonal IgM-enriched immunoglobulin therapy in sepsis: a review of clinical efficacy in relation to microbiological aetiology and severity of sepsis. J Intern Med 2006; 260: 509-16.","journal-title":"J Intern Med"},{"key":"2081_CR21","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1086\/421089","volume":"39","author":"J Pildal","year":"2004","unstructured":"Pildal J, Gotzsche PC. Polyclonal immunoglobulin for treatment of bacterial sepsis: a systematic review. Clin Infect Dis 2004; 39: 38-46.","journal-title":"Clin Infect Dis"},{"key":"2081_CR22","doi-asserted-by":"publisher","DOI":"10.1007\/s12630-021-01941-3","author":"M Leeies","year":"2021","unstructured":"Leeies M, Gershengorn HB, Charbonney E, et al. Intravenous immune globulin in septic shock: a Canadian national survey of critical care medicine and infectious disease specialist physicians. Can J Anesth 2021. DOI: https:\/\/doi.org\/10.1007\/s12630-021-01941-3.","journal-title":"Can J Anesth"},{"key":"2081_CR23","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-017-1764-4","author":"Y Iizuka","year":"2017","unstructured":"Iizuka Y, Sanui M, Sasabuchi Y, et al. Low-dose immunoglobulin G is not associated with mortality in patients with sepsis and septic shock. Crit Care 2017. DOI: https:\/\/doi.org\/10.1186\/s13054-017-1764-4.","journal-title":"Crit Care"}],"container-title":["Canadian Journal of Anesthesia\/Journal canadien d'anesth\u00e9sie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12630-021-02081-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12630-021-02081-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12630-021-02081-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,3]],"date-time":"2024-01-03T19:19:17Z","timestamp":1704309557000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12630-021-02081-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,10]]},"references-count":23,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2021,11]]}},"alternative-id":["2081"],"URL":"https:\/\/doi.org\/10.1007\/s12630-021-02081-4","relation":{},"ISSN":["0832-610X","1496-8975"],"issn-type":[{"type":"print","value":"0832-610X"},{"type":"electronic","value":"1496-8975"}],"subject":[],"published":{"date-parts":[[2021,8,10]]},"assertion":[{"value":"20 November 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 August 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"None.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}},{"value":"Supported by funds from the Dr. Lyonel G. Israels Chair in Hematology and the University of Manitoba Department of Anesthesiology.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding statement"}},{"value":"This submission was handled by Dr. Sangeeta Mehta, Associate Editor, <i>Canadian Journal of Anesthesia\/Journal canadien d\u2019anesth\u00e9sie.<\/i>","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Editorial responsibility"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}